DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors

DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors

The search for innovative therapeutic strategies remains critical in addressing cancer, one of the leading global health challenges. Ribosomal S6 Kinase 2 (RSK2), a serine/threonine kinase, has emerged as a promising target for cancer therapy because it is implicated in oncogenic signaling. Herein,...

Full description

Saved in:
Bibliographic Details
Main Authors: El Mehdi Karim, Meriem Khedraoui, Abdelkbir Errougui, Yasir S. Raouf, Abdelouahid Samadi, Samir Chtita
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Scientific African
Subjects:
RSK2 inhibitors
Molecular docking
ADME-Tox profiling
Molecular dynamics
MM-GBSA
Pyran derivatives
Online Access:http://www.sciencedirect.com/science/article/pii/S2468227625000523
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2468227625000523

Similar Items